$0.00
0.00%
Nasdaq, Fri, Sep 27 2024
ISIN
US40434H1041
Symbol
HTGM
Sector
Industry

HTG Molecular Diagnostics, Inc. Stock price

$0.00
+0.00 0.00% 1M
-0.00 86.67% 6M
-0.00 84.62% YTD
-0.37 99.95% 1Y
-69.96 100.00% 3Y
-111.85 100.00% 5Y
-2,478.60 100.00% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.00 0.00%
ISIN
US40434H1041
Symbol
HTGM
Sector
Industry

Key metrics

Market capitalization $0.00
EBIT (operating result TTM) EBIT $-19.59m
Short interest 0.12%

Is HTG Molecular Diagnostics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

HTG Molecular Diagnostics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast HTG Molecular Diagnostics, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast HTG Molecular Diagnostics, Inc.:

Buy
100%

Financial data from HTG Molecular Diagnostics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Annually
Dec '22
+/-
%
6.37 6.37
29% 29%
100%
- Direct Costs 4.57 4.57
12% 12%
72%
1.79 1.79
63% 63%
28%
- Selling and Administrative Expenses 15 15
3% 3%
233%
- Research and Development Expense 6.78 6.78
3% 3%
106%
-20 -20
16% 16%
-311%
- Depreciation and Amortization 1 1
15% 15%
16%
EBIT (Operating Income) EBIT -21 -21
14% 14%
-327%
Net Profit -22 -22
26% 26%
-339%

In millions USD.

Don't miss a Thing! We will send you all news about HTG Molecular Diagnostics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

HTG Molecular Diagnostics, Inc. Stock News

Neutral
GlobeNewsWire
more than one year ago
TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery business.
Neutral
GlobeNewsWire
more than one year ago
TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results for the quarter ended March 31, 2023 and provided recent drug discovery business highlights.
Neutral
GlobeNewsWire
more than one year ago
TUCSON, Ariz., Jan. 09, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today provided an update on the progress of its drug discovery business unit, including the filing of a patent application directed towards its f...
More HTG Molecular Diagnostics, Inc. News

Company Profile

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It offers instruments, reagents and services for molecular profiling applications. The firm serves biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Head office United States
CEO John Lubniewski
Founded 1997
Website www.htgmolecular.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today